Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 163, 105337
- https://doi.org/10.1016/j.phrs.2020.105337
Abstract
No abstract availableKeywords
Funding Information
- SCOHIA PHARMA, Inc.
- Takeda Pharmaceutical Company Limited
This publication has 48 references indexed in Scilit:
- Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and AdiposityScience Translational Medicine, 2013
- Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organTherapeutic Advances in Gastroenterology, 2013
- Linking Long-Term Dietary Patterns with Gut Microbial EnterotypesScience, 2011
- Differential Metabolic Impact of Gastric Bypass Surgery Versus Dietary Intervention in Obese Diabetic Subjects Despite Identical Weight LossScience Translational Medicine, 2011
- Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)Proceedings of the National Academy of Sciences of the United States of America, 2011
- Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemiaMolecular BioSystems, 2011
- Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesMetabolomics, 2009
- Human gut microbes associated with obesityNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences of the United States of America, 2005